Christoph Ullmer
5PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 21, 2024
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies.Andrea Chicca, Daniel Batora, Christoph Ullmer
|Feb 15, 2022
Elevated Levels of Growth/Differentiation Factor-15 in the Aqueous Humor and Serum of Glaucoma Patients.Rupalatha Maddala, Leona T Y Ho, Shruthi Karnam
|Jan 22, 2020
Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes.Matthias V Westphal, Roman C Sarott, Elisabeth A Zirwes
|Sep 22, 2019
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.Richard Frederick Porter, Anna-Maria Szczesniak, James Thomas Toguri
|May 02, 2019
Efficacy of simultaneous VEGF-A/ANG-2 neutralization in suppressing spontaneous choroidal neovascularization.Richard H Foxton, Sabine Uhles, Sabine Grüner
Pageof 1
Frequent Collaborators
2 joint publications
Uwe Grether
1 joint publications
Richard Frederick Porter
1 joint publications
Brent Johnston
1 joint publications
Christian Lehmann
1 joint publications
Matthias V Westphal
1 joint publications
Roman C Sarott
1 joint publications
Erick M Carreira
1 joint publications
Robin R Vann
1 joint publications
Andrea Chicca
1 joint publications
Daniel Batora
